Navigation Links
Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
Date:2/21/2008

ose from the $1,866.4 million write-off of in-process research and development ("IPR&D") acquired as part of the $2.6 billion acquisition of New River; this amount represents the value of the acquired development projects, including VYVANSE for use in adult patients. Excluding IPR&D, operating income rose by $204.1 million compared to 2006, primarily due to revenue growth.

Cash inflow from operating activities for the year to December 31, 2007 decreased by 11% to $474.7 million (2006: $531.9 million). Excluding upfront payments and milestones in respect of in-licensed technology of $155.9 million in 2007 and $80.5 million in 2006 (see section 4 - R&D below for details), cash inflow from operating activities for the year to December 31, 2007 increased by 3% to $630.6 million (2006: $612.4 million). This increase is lower than the increase in operating income (excluding IPR&D) of $204.1 million primarily as a result of increased receivables generated by higher sales in December 2007 over December 2006 and increases in inventory to support new products.

Cash, cash equivalents and restricted cash at December 31, 2007 totaled $802.0 million (December 31, 2006: $1,156.7 million). The decrease of $354.7 million was primarily due to the acquisition of New River in April 2007 being partly funded from Shire's pre-acquisition cash resources.

Summary of Q4 2007

Revenues from continuing operations for the three months to December 31, 2007 increased by 46% to $724.5 million (2006: $497.0 million).

Operating income for the three months to December 31, 2007 was $232.2 million (2006: $80.4 million). The increase primarily resulted from higher revenues and related earnings in Q4 2007 (compared to Q4 2006) and gains on disposal of non-core products of $115.7 million (2006: $nil), which were partially offset by upfront payments for in-licensed technology totaling $75.0 million (2006: $nil).

Cash inflow from operating activities for the three mo
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Correction Re Website
2. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
3. Shire Engages Palio
4. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
5. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
6. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire plc: Board Changes
9. David Mott Appointed Non Executive Director at Shire
10. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
11. Shire Divests Non-Core Product Portfolio to Almirall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... ... pumps and process equipment, announces the appointment of Dennis Rawle as European Director ... industrial industries. Most recently, he was General Manager and Technical Sales Manager for ...
(Date:8/4/2015)... 4, 2015 New ... journal serving the international surgical ... provider of scientific, technical, and medical information products and ... International Journal of Surgery Open ( IJS ... areas of surgery. This peer-reviewed, online-only journal will make ...
(Date:8/4/2015)...   California Cryobank Stem Cell Services LLC (dba ... an east coast cord blood and reproductive tissue bank ... tristate area. LifeLine clients will maintain full access to ... honored. Since 1991, LifeLine has provided a ... eggs, embryos, and cord blood stem cells. LifeLine Cryogenics was ...
(Date:8/3/2015)... -- At the 11th hour, ... shortfall of Jude Liversage,s campaign so the ... time.      (Photo: http://photos.prnewswire.com/prnh/20150803/254228 ) ... The Selective Dorsal Rhizotomy (SDR) procedure reduced the ... his wish to kick a ball around like his ...
Breaking Biology Technology:Dennis Rawle Joins Graphite Metallizing Corporation 2Elsevier Announces the Launch of International Journal of Surgery Open 2Elsevier Announces the Launch of International Journal of Surgery Open 3Elsevier Announces the Launch of International Journal of Surgery Open 4FamilyCord Announces Acquisition of LifeLine Cryogenics 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3
... Alcohol, All-Natural Formula Avoids Pitfalls of Alcohol-Based SanitizersCHARLOTTE, N.C., ... for individuals to feel helpless to protect themselves and ... infection and the spread of illnesses such as Swine ... and rub your hands clean. Remi-D, an all-natural hand ...
... SynCo Bio Partners B.V. (Amsterdam,The Netherlands), the cGMP ... Industry Excellence (ViE) award for,Best Contract Manufacturing Organization (CMO) ... World Vaccine Congress on the 22nd of April and ... and manufacturing,staff on behalf of its clients over the ...
... China-Biotics,Inc. (Nasdaq: CHBT ) ("China-Biotics," "the ... research, development, marketing and,distribution of probiotics products ( ... will present at the upcoming,China Rising Conference hosted ... May 18,2009. , The ...
Cached Biology Technology:Swine Flu a Reminder: Using Hand Sanitizers Like Remi-D Helps Fight Infection 2SynCo Bio Partners Wins Best Contract Manufacturing Organization 2009 ViE Award 2China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 2China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 3
(Date:7/21/2015)... July 21, 2015 Today, ZTE announced its ... as well as expected revenues in 2015 that relate to sales ... revenue guidance of approximately 2,200 MSEK for 2015. Jörgen ... leading smartphone manufacturer in China and we ... 02 5 for Axon , ...
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
(Date:7/9/2015)... , July 9, 2015  Unchained Labs ... announcing its acquisition of Avid Nano. Avid Nano ... scattering (DLS) systems.    Also today, ... fastest and easiest to use protein sizing system. ... measures a protein,s hydrodynamic size, size distribution, aggregation ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... has improved a strain of E. coli, making it grow faster. ... decimate it. "The average person hears E. coli and ... poisoning, but we,ve developed a strain of E. coli that is ... in vaccines or gene therapy," said Yong-Su Jin, a U of ...
... Environmental scientists at Clemson University have received a ... Energy to study how plutonium, a byproduct of used ... implications for nuclear cleanup efforts and could help the ... by long-term nuclear waste disposal. "Plutonium contamination in ...
... A new field study confirms that an invasive ... grass species, suggesting it will continue to spread across ... millions of acres of grazing land almost worthless. ... the Agricultural Research Service, was one of the most ...
Cached Biology News:This faster-growing E. coli strain's a good thing 2Clemson researcher will study plutonium underground for Energy Department 2Invading weed threatens devastation to western rangelands 2Invading weed threatens devastation to western rangelands 3
Request Info...
Human RUNX2/CBFA1 MAb (Clone 232902)...
... Streptavidin-Horseradish Peroxidase Conjugate, ... to reporter enzyme molecules ... and in situ hybridization ... Blotting & Labeling & ...
...
Biology Products: